Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT04132817 |
Title | A Study of Multiple Immune and Disease Treatment Combinations in Participants With ER+HER2- Breast Cancer That Has Spread |
Recruitment | Completed |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Bristol-Myers Squibb |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Local Institution | Los Angeles | California | 90033 | United States | Details | |
Local Institution - 0003 | Sacramento | California | 95817 | United States | Details | |
Local Institution - 0009 | Aurora | Colorado | 80045 | United States | Details | |
Local Institution - 0002 | Saint Louis | Missouri | 63110 | United States | Details | |
Local Institution - 0008 | New York | New York | 10016 | United States | Details | |
Local Institution | Pittsburgh | Pennsylvania | 15213 | United States | Details | |
Local Institution | Dallas | Texas | 75390 | United States | Details | |
South Texas Accelerated Research Therapeutics | San Antonio | Texas | 78229 | United States | Details |